Literature DB >> 8213453

The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size.

R Charney1, M Cohen.   

Abstract

The role of coronary collateral circulation in limiting ischemia and infarction has been studied prospectively. Transient occlusion of a coronary artery angioplasty has provided evidence that collateral circulation decreases wall motion abnormalities, ST segment changes, and lactate production. Patients who have collateral flow also have a better outcome after coronary artery dissection and acute closure than patients without collateral flow. Collateral circulation also limits infarct size during acute myocardial infarction with and without thrombolysis. Although collateral flow may decrease coronary artery bypass graft patency in certain subgroups of patients, the perioperative infarct rate and mortality is decreased. Growth factors have been identified that increase the development collateral circulation and may improve ventricular function in the setting of myocardial infarction.

Entities:  

Mesh:

Year:  1993        PMID: 8213453     DOI: 10.1016/0002-8703(93)90710-q

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  17 in total

Review 1.  Therapeutic angiogenesis.

Authors:  T D Henry
Journal:  BMJ       Date:  1999-06-05

Review 2.  The open-artery hypothesis revisited.

Authors:  Alireza Zarrabi; Hossein Eftekhari; S Ward Casscells; Mohammad Madjid
Journal:  Tex Heart Inst J       Date:  2006

3.  Endocan: a novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion.

Authors:  Samim Emet; Ali Elitok; Imran Onur; Mehmet Kocaaga; Ahmet Kaya Bilge; Huseyin Oflaz; Berrin Umman; Aytac Oncul; Zehra Bugra; Kamil Adalet; Fehmi Mercanoglu
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

4.  Clinical characteristics of occluded culprit arteries and collaterals in patients with non-ST-segment elevation myocardial infarction and impact on clinical outcomes.

Authors:  Hui-Jeong Hwang; Chang-Bum Park; Jin-Man Cho; Eun-Sun Jin; Il Suk Sohn; Dong-Hee Kim; Chong-Jin Kim
Journal:  Exp Ther Med       Date:  2018-08-13       Impact factor: 2.447

Review 5.  Effects of exercise training on coronary collateralization and control of collateral resistance.

Authors:  Cristine L Heaps; Janet L Parker
Journal:  J Appl Physiol (1985)       Date:  2011-05-12

6.  Association of arterial calcification with chronic limb ischemia in patients with peripheral artery disease.

Authors:  Sara L Zettervall; Andre P Marshall; Paul Fleser; Raul J Guzman
Journal:  J Vasc Surg       Date:  2017-09-01       Impact factor: 4.268

7.  Simultaneous measurement and modulation of multiple physiological parameters in the isolated heart using optical techniques.

Authors:  Peter Lee; Ping Yan; Paul Ewart; Peter Kohl; Leslie M Loew; Christian Bollensdorff
Journal:  Pflugers Arch       Date:  2012-08-12       Impact factor: 3.657

8.  The presence of angiographic collaterals in non-ST elevation myocardial infarction is a predictor of long-term clinical outcomes.

Authors:  Angela M Kloepfer; Lewis C Lipson; Ellen C Keeley
Journal:  Catheter Cardiovasc Interv       Date:  2013-06-25       Impact factor: 2.692

9.  Sex differences in mortality following acute coronary syndromes.

Authors:  Jeffrey S Berger; Laine Elliott; Dianne Gallup; Matthew Roe; Christopher B Granger; Paul W Armstrong; R John Simes; Harvey D White; Frans Van de Werf; Eric J Topol; Judith S Hochman; L Kristin Newby; Robert A Harrington; Robert M Califf; Richard C Becker; Pamela S Douglas
Journal:  JAMA       Date:  2009-08-26       Impact factor: 56.272

10.  Significance of perfusion of the infarct related coronary artery for susceptibility to ventricular tachyarrhythmias in patients with previous myocardial infarction.

Authors:  H V Huikuri; M J Koistinen; K E Airaksinen; M J Ikäheimo
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.